10:05 AM EST - Knight Therapeutics Inc. : Announced today that its Colombian affiliate, Biotoscana Farma S.A., is in the process of assuming full commercial activities for Exelon® (rivastigmine) in Colombia upon successful transfer of the marketing authorization. Knight Therapeutics Inc.
shares T.GUD are trading down $0.02 at $5.44.
